Injectable sustained release implant having a bioerodible matrix core and a bioerodible skin

Details for Australian Patent Application No. 2004292957 (hide)

Owner pSivida US Inc.

Inventors Guo, Hong; Shimizu, Robert W.; Ashton, Paul; Chou, Kang-Jye; Watson, David A.

Agent Shelston IP

Pub. Number AU-B-2004292957

PCT Pub. Number WO2005/051234

Priority 60/543,368 09.02.04 US; 10/714,549 13.11.03 US

Filing date 26 October 2004

Wipo publication date 9 June 2005

Acceptance publication date 9 September 2010

International Classifications

A61K 9/00 (2006.01) Medicinal preparations characterised by special physical form

A61K 9/20 (2006.01) Medicinal preparations characterised by special physical form - Pills, lozenges or tablets

Event Publications

15 June 2006 PCT application entered the National Phase

  PCT publication WO2005/051234 Priority application(s): WO2005/051234

29 June 2006 Change of Name(s) of Applicant(s), Section 104

  Control Delivery Systems, Inc. The name of the applicant has been changed to pSivida, Inc.

16 July 2009 Alteration of Name

  The name of the applicant has been altered to pSivida US Inc.

9 September 2010 Application Accepted

  Published as AU-B-2004292957

6 January 2011 Application for Amendment

  The nature of the amendment is as shown in the statement(s) filed 30 Nov 2010. Address for service in Australia - Shelston IP Level 21 60 Margaret Street Sydney NSW 2000 2005

28 April 2011 Amendment Made

  The nature of the amendment is as shown in the statement(s) filed 30 Nov 2010

12 May 2011 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004292966-Compositions and methods of treatment using L-type calcium channel blockers and cholinesterase inhibitors

2004292956-Compositions for achieving benefits in skin using key cellular metabolic intermediates